Steven J. Burakoff - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Molecular Biology, Immunology

216 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sawasdikosol S, Burakoff S. A perspective on HPK1 as a novel immuno-oncology drug target. Elife. 9. PMID 32896273 DOI: 10.7554/Elife.55122  0.314
2020 Sawasdikosol S, Zha R, Fisher TS, Alzabin S, Burakoff SJ. HPK1 Influences Regulatory T Cell Functions. Immunohorizons. 4: 382-391. PMID 32631900 DOI: 10.4049/immunohorizons.1900053  0.336
2019 Johnson E, McTigue M, Gallego RA, Johnson TW, Timofeevski S, Maestre M, Fisher TS, Kania R, Sawasdikosol S, Burakoff S, Cronin CN. Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation. The Journal of Biological Chemistry. PMID 31018963 DOI: 10.1074/Jbc.Ac119.007466  0.302
2013 Jin YJ, Cai CY, Mezei M, Ohlmeyer M, Sanchez R, Burakoff SJ. Identification of a novel binding site between HIV type 1 Nef C-terminal flexible loop and AP2 required for Nef-mediated CD4 downregulation. Aids Research and Human Retroviruses. 29: 725-31. PMID 23151229 DOI: 10.1089/Aid.2012.0286  0.325
2013 Sawasdikosol S, Zha R, Yang B, Burakoff S. HPK1 as a novel target for cancer immunotherapy. Immunologic Research. 54: 262-5. PMID 22477524 DOI: 10.1007/S12026-012-8319-1  0.423
2013 Moskalenko M, Pan M, Hashimoto D, Mortha A, Bernardo SG, Leboeuf M, Houghton A, Wolchok J, Burakoff S, Merad M, Saenger YM. Abstract A43: Therapeutic efficacy of antitumor monoclonal antibodies combined with chemotherapy depends on innate immunity and NK1.1- innate lymphoid cells. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-A43  0.401
2011 Germain RN, Burakoff SJ. A remembrance of Baruj Benacerraf (AAI '57) 1920-2011. Journal of Immunology (Baltimore, Md. : 1950). 187: 5465-9. PMID 22102728 DOI: 10.4049/Jimmunol.1190069  0.431
2011 Pedraza-Alva G, Mérida LB, del Rio R, Fierro NA, Cruz-Muñoz ME, Olivares N, Melchy E, Igras V, Holländer GA, Burakoff SJ, Rosenstein Y. CD43 regulates the threshold for T cell activation by targeting Cbl functions. Iubmb Life. 63: 940-8. PMID 21905200 DOI: 10.1002/Iub.554  0.479
2011 Cai CY, Zhang X, Sinko PJ, Burakoff SJ, Jin YJ. Two sorting motifs, a ubiquitination motif and a tyrosine motif, are involved in HIV-1 and simian immunodeficiency virus Nef-mediated receptor endocytosis. Journal of Immunology (Baltimore, Md. : 1950). 186: 5807-14. PMID 21482738 DOI: 10.4049/Jimmunol.1003506  0.36
2010 Jin YJ, Zhang X, Cai CY, Burakoff SJ. Alkylating HIV-1 Nef - a potential way of HIV intervention. Aids Research and Therapy. 7: 26. PMID 20659345 DOI: 10.1186/1742-6405-7-26  0.37
2010 Alzabin S, Pyarajan S, Yee H, Kiefer F, Suzuki A, Burakoff S, Sawasdikosol S. Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response. Cancer Immunology, Immunotherapy : Cii. 59: 419-29. PMID 19787351 DOI: 10.1007/S00262-009-0761-0  0.438
2009 Alzabin S, Bhardwaj N, Kiefer F, Sawasdikosol S, Burakoff S. Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation. Journal of Immunology (Baltimore, Md. : 1950). 182: 6187-94. PMID 19414772 DOI: 10.4049/Jimmunol.0802631  0.442
2008 Pyarajan S, Matejovic G, Pratt JC, Baksh S, Burakoff SJ. Interleukin-3 (IL-3)-induced c-fos activation is modulated by Gab2-calcineurin interaction. The Journal of Biological Chemistry. 283: 23505-9. PMID 18586679 DOI: 10.1074/Jbc.C800087200  0.33
2008 Jin YJ, Cai CY, Zhang X, Burakoff SJ. Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation. Journal of Immunology (Baltimore, Md. : 1950). 180: 7878-86. PMID 18523251 DOI: 10.4049/Jimmunol.180.12.7878  0.363
2007 Sawasdikosol S, Pyarajan S, Alzabin S, Matejovic G, Burakoff SJ. Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway. The Journal of Biological Chemistry. 282: 34693-9. PMID 17895239 DOI: 10.1074/Jbc.M707425200  0.368
2007 Maziarz RT, Groh V, Prendergast M, Fabbi M, Strominger JL, Burakoff SJ. Non—MHC—restricted target—cell lysis by a CD4−CD− TCRαβ T—cell line, as well as by TCR4gMδ T—cell lines, results from lymphokine—activated killing International Journal of Cancer. 48: 142-147. DOI: 10.1002/Ijc.2910480125  0.492
2006 Fragoso RC, Pyarajan S, Irie HY, Burakoff SJ. A CD8/Lck transgene is able to drive thymocyte differentiation. Journal of Immunology (Baltimore, Md. : 1950). 177: 6007-17. PMID 17056525 DOI: 10.4049/Jimmunol.177.9.6007  0.73
2005 Jin YJ, Cai CY, Zhang X, Zhang HT, Hirst JA, Burakoff SJ. HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. Journal of Immunology (Baltimore, Md. : 1950). 175: 3157-64. PMID 16116206 DOI: 10.4049/Jimmunol.175.5.3157  0.38
2004 Jin YJ, Zhang X, Boursiquot JG, Burakoff SJ. CD4 phosphorylation partially reverses Nef down-regulation of CD4. Journal of Immunology (Baltimore, Md. : 1950). 173: 5495-500. PMID 15494497 DOI: 10.4049/Jimmunol.173.9.5495  0.474
2004 Su MW, Pyarajan S, Chang JH, Yu CL, Jin YJ, Stierhof YD, Walden P, Burakoff SJ. Fratricide of CD8+ cytotoxic T lymphocytes is dependent on cellular activation and perforin-mediated killing. European Journal of Immunology. 34: 2459-70. PMID 15307178 DOI: 10.1002/Eji.200425096  0.804
2004 Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D, Modiano JF. Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells. The Journal of Pharmacology and Experimental Therapeutics. 311: 758-69. PMID 15231866 DOI: 10.1124/Jpet.104.070060  0.416
2004 Friedman JS, Alpdogan O, van den Brink MR, Liu C, Hurwitz D, Boyd A, Kupper TS, Burakoff SJ. Increasing T-cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 10: 448-60. PMID 15205666 DOI: 10.1016/J.Bbmt.2004.03.005  0.531
2004 Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, Welsh ML, Boyd A, Doctrow SR, Burakoff SJ. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood. 104: 2565-73. PMID 15205258 DOI: 10.1182/Blood-2003-11-3858  0.343
2004 Slavik JM, Lim DG, Burakoff SJ, Hafler DA. Rapamycin-resistant Proliferation of CD8+ T Cells Correlates with p27 kip1 Down-regulation and bcl-xL Induction, and is Prevented by an Inhibitor of Phosphoinositide 3-Kinase Activity Journal of Biological Chemistry. 279: 910-919. PMID 14573608 DOI: 10.1074/Jbc.M209733200  0.524
2003 Sawasdikosol S, Russo KM, Burakoff SJ. Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription Blood. 101: 3687-3689. PMID 12522005 DOI: 10.1182/Blood-2002-07-2316  0.302
2003 Fragoso R, Ren D, Zhang X, Su MW, Burakoff SJ, Jin YJ. Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. Journal of Immunology (Baltimore, Md. : 1950). 170: 913-21. PMID 12517957 DOI: 10.4049/Jimmunol.170.2.913  0.784
2002 Baksh S, Widlund HR, Frazer-Abel AA, Du J, Fosmire S, Fisher DE, DeCaprio JA, Modiano JF, Burakoff SJ. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Molecular Cell. 10: 1071-81. PMID 12453415 DOI: 10.1016/S1097-2765(02)00701-3  0.377
2002 Tkaczuk J, Yu CL, Baksh S, Milford EL, Carpenter CB, Burakoff SJ, McKay DB. Effect of anti-IL-2Ralpha antibody on IL-2-induced Jak/STAT signaling. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2: 31-40. PMID 12095053 DOI: 10.1034/J.1600-6143.2002.020107.X  0.323
2002 van den Brink MR, Burakoff SJ. Cytolytic pathways in haematopoietic stem-cell transplantation. Nature Reviews. Immunology. 2: 273-81. PMID 12001998 DOI: 10.1038/Nri775  0.414
2002 Ordemann R, Hutchinson R, Friedman J, Burakoff SJ, Reddy P, Duffner U, Braun TM, Liu C, Teshima T, Ferrara JL. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. The Journal of Clinical Investigation. 109: 1249-56. PMID 11994414 DOI: 10.1172/Jci14793  0.429
2002 Mulroy T, McMahon JA, Burakoff SJ, McMahon AP, Sen J. Wnt-1 and Wnt-4 regulate thymic cellularity. European Journal of Immunology. 32: 967-71. PMID 11920562 DOI: 10.1002/1521-4141(200204)32:4<967::Aid-Immu967>3.0.Co;2-6  0.344
2001 Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T, Ferrara JL, Burakoff SJ, van den Brink MR. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood. 97: 2886-95. PMID 11313285 DOI: 10.1182/Blood.V97.9.2886  0.501
2001 Friedman JS, Rebel VI, Derby R, Bell K, Huang TT, Kuypers FA, Epstein CJ, Burakoff SJ. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. The Journal of Experimental Medicine. 193: 925-34. PMID 11304553 DOI: 10.1084/Jem.193.8.925  0.371
2001 Su MW, Yu CL, Burakoff SJ, Jin YJ. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation. Journal of Immunology (Baltimore, Md. : 1950). 166: 3975-82. PMID 11238643 DOI: 10.4049/Jimmunol.166.6.3975  0.769
2001 Slavik JM, Lim DG, Burakoff SJ, Hafler DA. Uncoupling p70s6 kinase activation and proliferation: Rapamycin-resistant proliferation of human CD8+ T lymphocytes1 Journal of Immunology. 166: 3201-3209. PMID 11207273 DOI: 10.4049/Jimmunol.166.5.3201  0.539
2001 Pedraza-Alva G, Sawasdikosol S, Liu YC, Mérida LB, Cruz-Muñoz ME, Oceguera-Yañez F, Burakoff SJ, Rosenstein Y. Regulation of Cbl molecular interactions by the co-receptor molecule CD43 in human T cells. The Journal of Biological Chemistry. 276: 729-37. PMID 11024037 DOI: 10.1074/Jbc.M008494200  0.485
2000 Pratt JC, Igras VE, Maeda H, Baksh S, Gelfand EW, Burakoff SJ, Neel BG, Gu H. Cutting edge: Gab2 mediates an inhibitory phosphatidylinositol 3'-kinase pathway in T cell antigen receptor signaling Journal of Immunology. 165: 4158-4163. PMID 11035047 DOI: 10.4049/Jimmunol.165.8.4158  0.409
2000 Baksh S, Burakoff SJ. The role of calcineurin in lymphocyte activation. Seminars in Immunology. 12: 405-15. PMID 10995587 DOI: 10.1006/Smim.2000.0221  0.402
2000 Santana MA, Pedraza-Alva G, Olivares-Zavaleta N, Madrid-Marina V, Horejsi V, Burakoff SJ, Rosenstein Y. CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes. The Journal of Biological Chemistry. 275: 31460-8. PMID 10908570 DOI: 10.1074/jbc.M005231200  0.361
2000 van den Brink MR, Moore E, Ferrara JL, Burakoff SJ. Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation. 69: 446-9. PMID 10706060 DOI: 10.1097/00007890-200002150-00026  0.363
2000 Yu CL, Jin YJ, Burakoff SJ. Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation Journal of Biological Chemistry. 275: 599-604. PMID 10617656 DOI: 10.1074/Jbc.275.1.599  0.308
2000 van Den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, Burakoff SJ. Fas-deficient lpr mice are more susceptible to graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 164: 469-80. PMID 10605044 DOI: 10.4049/Jimmunol.164.1.469  0.355
2000 McKay DB, Tao L, Sawasdikosol S, Burakoff SJ. ALLOPEPTIDE/MHC-TCR AFFINITY DETERMINES PHOSPHORYLATION KINETICS. Transplantation. 69: S131. DOI: 10.1097/00007890-200004271-00077  0.301
1999 Jin YJ, Yu CL, Burakoff SJ. Human 70-kDa SHP-1L differs from 68-kDa SHP-1 in its C-terminal structure and catalytic activity. The Journal of Biological Chemistry. 274: 28301-7. PMID 10497187 DOI: 10.1074/Jbc.274.40.28301  0.351
1999 Tang J, Sawasdikosol S, Chang JH, Burakoff SJ. SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling. Proceedings of the National Academy of Sciences of the United States of America. 96: 9775-80. PMID 10449770 DOI: 10.1073/Pnas.96.17.9775  0.477
1999 van den Brink MR, Kapeller R, Pratt JC, Chang JH, Burakoff SJ. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. The Journal of Biological Chemistry. 274: 11178-85. PMID 10196203 DOI: 10.1074/Jbc.274.16.11178  0.41
1999 Pratt JC, Sawasdikosol S, van den Brink MR, Burakoff SJ. Positive and negative signaling pathways. Transplantation Proceedings. 31: 772-4. PMID 10083327 DOI: 10.1016/S0041-1345(98)01760-6  0.377
1999 Meng W, Sawasdikosol S, Burakoff SJ, Eck MJ. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature. 398: 84-90. PMID 10078535 DOI: 10.1038/18050  0.305
1999 Gu H, Pratt JC, Burakoff SJ, Neel BG. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Molecular Cell. 2: 729-40. PMID 9885561 DOI: 10.1016/S1097-2765(00)80288-9  0.338
1998 Chang JH, Pratt JC, Sawasdikosol S, Kapeller R, Burakoff SJ. The small GTP-binding protein Rho potentiates AP-1 transcription in T cells. Molecular and Cellular Biology. 18: 4986-93. PMID 9710582 DOI: 10.1128/Mcb.18.9.4986  0.384
1998 Pedraza-Alva G, Mérida LB, Burakoff SJ, Rosenstein Y. T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation. The Journal of Biological Chemistry. 273: 14218-24. PMID 9603925 DOI: 10.1074/Jbc.273.23.14218  0.49
1998 Holländer GA, Zuklys S, Morel C, Mizoguchi E, Mobisson K, Simpson S, Terhorst C, Wishart W, Golan DE, Bhan AK, Burakoff SJ. Monoallelic expression of the interleukin-2 locus. Science (New York, N.Y.). 279: 2118-21. PMID 9516115 DOI: 10.1126/Science.279.5359.2118  0.359
1997 McKay D, Irie H, Holländer G, Burakoff S. Intracellular signals associated with in vivo T cell anergy Immunology Letters. 56: 245-246. DOI: 10.1016/S0165-2478(97)85977-9  0.448
1997 Irie H, Crooks M, Littman D, Burakoff S. The role of CD8β in T cell development may be due to its regulation of CD8α-associated Lck kinase activity Immunology Letters. 56: 57. DOI: 10.1016/S0165-2478(97)85216-9  0.432
1996 Pedraza-Alva G, Mérida LB, Burakoff SJ, Rosenstein Y. CD43-specific activation of T cells induces association of CD43 to Fyn kinase. The Journal of Biological Chemistry. 271: 27564-8. PMID 8910342 DOI: 10.1074/Jbc.271.44.27564  0.479
1996 Fruman DA, Pai SY, Klee CB, Burakoff SJ, Bierer BE. Measurement of Calcineurin Phosphatase Activity in Cell Extracts Methods (San Diego, Calif.). 9: 146-54. PMID 8812656 DOI: 10.1006/Meth.1996.0020  0.363
1996 Lee-Fruman KK, Collins TL, Burakoff SJ. Role of the Lck Src homology 2 and 3 domains in protein tyrosine phosphorylation Journal of Biological Chemistry. 271: 25003-25010. PMID 8798782 DOI: 10.1074/Jbc.271.40.25003  0.485
1996 Lorenz U, Ravichandran KS, Burakoff SJ, Neel BG. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proceedings of the National Academy of Sciences of the United States of America. 93: 9624-9. PMID 8790380 DOI: 10.1073/Pnas.93.18.9624  0.409
1996 Wang B, Holländer GA, Nichogiannopoulou A, Simpson SJ, Orange JS, Gutierrez-Ramos JC, Burakoff SJ, Biron CA, Terhorst C. Natural killer cell development is blocked in the context of aberrant T lymphocyte ontogeny International Immunology. 8: 939-949. PMID 8671683 DOI: 10.1093/intimm/8.6.939  0.337
1996 Holländer GA, Castigli E, Kulbacki R, Su M, Burakoff SJ, Gutierrez-Ramos JC, Geha RS. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 93: 4994-8. PMID 8643517 DOI: 10.1073/Pnas.93.10.4994  0.539
1996 Wesselborg S, Fruman DA, Sagoo JK, Bierer BE, Burakoff SJ. Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp). The Journal of Biological Chemistry. 271: 1274-7. PMID 8576111 DOI: 10.1074/Jbc.271.3.1274  0.468
1996 Ravichandran KS, Collins TL, Burakoff SJ. CD4 and signal transduction Current Topics in Microbiology and Immunology. 205: 47-62. PMID 8575197 DOI: 10.1007/978-3-642-79798-9_3  0.46
1996 Dunussi-Joannopoulos K, Weinstein H, Nickerson P, Strom T, Burakoff S, Croop J, Arceci R. Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML Blood. 87: 2938-2946. DOI: 10.1182/Blood.V87.7.2938.Bloodjournal8772938  0.475
1995 Zhou MM, Harlan JE, Wade WS, Crosby S, Ravichandran KS, Burakoff SJ, Fesik SW. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc Journal of Biological Chemistry. 270: 31119-31123. PMID 8537373 DOI: 10.1074/Jbc.270.52.31119  0.313
1995 Holländer GA, Wang B, Nichogiannopoulou A, Platenburg PP, van Ewijk W, Burakoff SJ, Gutierrez-Ramos JC, Terhorst C. Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature. 373: 350-3. PMID 7830770 DOI: 10.1038/373350A0  0.427
1995 Fruman DA, Pai SY, Burakoff SJ, Bierer BE. Characterization of a mutant calcineurin A alpha gene expressed by EL4 lymphoma cells. Molecular and Cellular Biology. 15: 3857-63. PMID 7791792 DOI: 10.1128/Mcb.15.7.3857  0.368
1995 Irie HY, Ravichandran KS, Burakoff SJ. CD8 beta chain influences CD8 alpha chain-associated Lck kinase activity. The Journal of Experimental Medicine. 181: 1267-73. PMID 7699318 DOI: 10.1084/Jem.181.4.1267  0.391
1995 Holländer GA, Simpson SJ, Mizoguchi E, Nichogiannopoulou A, She J, Gutierrez-Ramos JC, Bhan AK, Burakoff SJ, Wang B, Terhorst C. Severe colitis in mice with aberrant thymic selection. Immunity. 3: 27-38. PMID 7621076 DOI: 10.1016/1074-7613(95)90156-6  0.436
1995 Zhou MM, Meadows RP, Logan TM, Yoon HS, Wade WS, Ravichandran KS, Burakoff SJ, Fesik SW. Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proceedings of the National Academy of Sciences of the United States of America. 92: 7784-8. PMID 7544002 DOI: 10.1073/Pnas.92.17.7784  0.401
1995 Fruman DA, Wood MA, Gjertson CK, Katz HR, Burakoff SJ, Bierer BE. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells. European Journal of Immunology. 25: 563-71. PMID 7533090 DOI: 10.1002/Eji.1830250239  0.36
1995 Venkataraman L, Burakoff SJ, Sen R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells Journal of Experimental Medicine. 181: 1091-1099. PMID 7532676 DOI: 10.1084/Jem.181.3.1091  0.436
1995 Sawasdikosol S, Ravichandran KS, Lee KK, Chang JH, Burakoff SJ. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. The Journal of Biological Chemistry. 270: 2893-6. PMID 7531694 DOI: 10.1074/Jbc.270.7.2893  0.422
1995 Ravichandran KS, Lorenz U, Shoelson SE, Burakoff SJ. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS. Molecular and Cellular Biology. 15: 593-600. PMID 7529871 DOI: 10.1128/Mcb.15.2.593  0.379
1995 Ravichandran KS, Pratt JC, Sawasdikosol S, Irie HY, Burakoff SJ. Coreceptors and adapter proteins in T-cell signaling. Annals of the New York Academy of Sciences. 766: 117-33. PMID 7486649 DOI: 10.1111/J.1749-6632.1995.Tb26656.X  0.424
1994 Holländer GA, Bierer BE, Burakoff SJ. Molecular and biological actions of cyclosporin A and FK506 on T cell development and function. Transfusion Science. 15: 207-20. PMID 10155542 DOI: 10.1016/0955-3886(94)90133-3  0.469
1994 Ravichandran KS, Burakoff SJ. Evidence for differential intracellular signaling via CD4 and CD8 molecules. The Journal of Experimental Medicine. 179: 727-32. PMID 8294879 DOI: 10.1084/Jem.179.2.727  0.432
1994 Burakoff SJ, Lafferty KJ. Transplantation. Antigen, co-stimulators and cytokines: regulators of allogeneic interactions. Current Opinion in Immunology. 5: 745-6. PMID 8240737 DOI: 10.1016/0952-7915(93)90131-B  0.311
1994 Lorenz U, Ravichandran KS, Pei D, Walsh CT, Burakoff SJ, Neel BG. Lck-dependent tyrosyl phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells. Molecular and Cellular Biology. 14: 1824-34. PMID 8114715 DOI: 10.1128/mcb.14.3.1824-1834.1994  0.516
1994 Sen J, Shinkai Y, Alt FW, Sen R, Burakoff SJ. Nuclear factors that mediate intrathymic signals are developmentally regulated Journal of Experimental Medicine. 180: 2321-2327. PMID 7964504 DOI: 10.1084/Jem.180.6.2321  0.467
1994 Collins TL, Kassner PD, Bierer BE, Burakoff SJ. Adhesion receptors in lymphocyte activation Current Opinion in Immunology. 6: 385-393. PMID 7917106 DOI: 10.1016/0952-7915(94)90117-1  0.47
1994 Holländer GA, Fruman DA, Bierer BE, Burakoff SJ. Disruption of T cell development and repertoire selection by calcineurin inhibition in vivo. Transplantation. 58: 1037-43. PMID 7526495 DOI: 10.1097/00007890-199411150-00011  0.49
1994 Fruman DA, Burakoff SJ, Bierer BE. Immunophilins in protein folding and immunosuppression. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 8: 391-400. PMID 7513288 DOI: 10.1096/Fasebj.8.6.7513288  0.301
1993 Macklis RM, Mauch PM, Thompson L, Burakoff SJ, Smith BR. Phenotypic and functional analysis of expanded natural killer cell subpopulations in Hodgkin's disease patients treated with lymphoid irradiation. Oncology. 50: 323-8. PMID 8497384 DOI: 10.1159/000227203  0.376
1993 Ravichandran KS, Lee KK, Songyang Z, Cantley LC, Burn P, Burakoff SJ. Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation. Science (New York, N.Y.). 262: 902-5. PMID 8235613 DOI: 10.1126/Science.8235613  0.416
1993 Collins TL, Hahn WC, Bierer BE, Burakoff SJ. CD4, CD8 and CD2 in T cell adhesion and signaling Current Topics in Microbiology and Immunology. 184: 223-233. PMID 7906216 DOI: 10.1007/978-3-642-78253-4_18  0.523
1993 Collins TL, Burakoff SJ. Tyrosine kinase activity of CD4-associated p56lck may not be required for CD4-dependent T-cell activation Proceedings of the National Academy of Sciences of the United States of America. 90: 11885-11889. PMID 7505449 DOI: 10.1073/Pnas.90.24.11885  0.492
1992 Macklis RM, Mauch PM, Burakoff SJ, Smith BR. Lymphoid irradiation results in long-term increases in natural killer cells in patients treated for Hodgkin's disease. Cancer. 69: 778-83. PMID 1730127 DOI: 10.1002/1097-0142(19920201)69:3<778::Aid-Cncr2820690327>3.0.Co;2-E  0.475
1992 Rosenstein Y, Park JK, Hahn WC, Rosen FS, Bierer BE, Burakoff SJ. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature. 354: 233-5. PMID 1683685 DOI: 10.1038/354233A0  0.514
1992 Sleckman BP, Shin J, Igras VE, Collins TL, Strominger JL, Burakoff SJ. Disruption of the CD4-p56lck complex is required for rapid internalization of CD4 Proceedings of the National Academy of Sciences of the United States of America. 89: 7566-7570. PMID 1502168 DOI: 10.1073/Pnas.89.16.7566  0.437
1992 Fruman DA, Mather PE, Burakoff SJ, Bierer BE. Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas. European Journal of Immunology. 22: 2513-7. PMID 1382988 DOI: 10.1002/Eji.1830221008  0.508
1992 Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proceedings of the National Academy of Sciences of the United States of America. 89: 3686-90. PMID 1373887 DOI: 10.1073/Pnas.89.9.3686  0.433
1992 Hahn WC, Rosenstein Y, Calvo V, Burakoff SJ, Bierer BE. A distinct cytoplasmic domain of CD2 regulates ligand avidity and T-cell responsiveness to antigen. Proceedings of the National Academy of Sciences of the United States of America. 89: 7179-83. PMID 1353888 DOI: 10.1073/Pnas.89.15.7179  0.511
1992 Moore JP, Simpson G, McKeating JA, Burakoff SJ, Schreiber SL, Weiss RA. CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro. Virology. 188: 537-44. PMID 1316672 DOI: 10.1016/0042-6822(92)90508-M  0.355
1991 Bierer BE, Burakoff SJ. T cell receptors: adhesion and signaling. Advances in Cancer Research. 56: 49-76. PMID 2028842 DOI: 10.1016/S0065-230X(08)60477-7  0.529
1991 Park JK, Rosenstein YJ, Remold-O'Donnell E, Bierer BE, Rosen FS, Burakoff SJ. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome. Nature. 350: 706-9. PMID 2023632 DOI: 10.1038/350706A0  0.565
1991 Sekaly RP, Croteau G, Bowman M, Scholl P, Burakoff S, Geha RS. The CD4 molecule is not always required for the T cell response to bacterial enterotoxins Journal of Experimental Medicine. 173: 367-371. PMID 1988539 DOI: 10.1084/Jem.173.2.367  0.538
1991 Bowman MR, MacFerrin KD, Schreiber SL, Burakoff SJ. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. Proceedings of the National Academy of Sciences of the United States of America. 87: 9052-6. PMID 1978941 DOI: 10.1073/Pnas.87.22.9052  0.43
1991 Sakamoto H, Michaelson J, Jones WK, Bhan AK, Abhyankar S, Silverstein M, Golan DE, Burakoff SJ, Ferrara JL. Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease. Proceedings of the National Academy of Sciences of the United States of America. 88: 10890-4. PMID 1835792 DOI: 10.1073/Pnas.88.23.10890  0.44
1991 Bierer BE, Schreiber SL, Burakoff SJ. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation. European Journal of Immunology. 21: 439-45. PMID 1705513 DOI: 10.1002/Eji.1830210228  0.539
1990 Bierer BE, Burakoff SJ. T-lymphocyte activation: the biology and function of CD2 and CD4. Immunological Reviews. 111: 267-94. PMID 2483402 DOI: 10.1111/J.1600-065X.1989.Tb00549.X  0.499
1990 Veillette A, Sleckman BP, Ratnofsky S, Bolen JB, Burakoff SJ. The cytoplasmic domain of CD4 is required for stable association with the lymphocyte-specific tyrosine protein kinase p56lck. European Journal of Immunology. 20: 1397-400. PMID 2369920 DOI: 10.1002/Eji.1830200628  0.526
1990 Ferrara JLM, Mauch P, Van Dijken PJ, Crosier KE, Michaelson J, Burakoff SJ. Evidence that anti-asialo GM<inf>1</inf> in vivo improves engraftment of t cell-depleted bone marrow in hybrid recipients Transplantation. 49: 134-138. PMID 2301005 DOI: 10.1097/00007890-199001000-00030  0.401
1990 Mentzer SJ, Burakoff SJ, Barbosa JA. Induction of HLA class I surface expression recruits low-affinity cytolytic T lymphocytes. International Archives of Allergy and Immunology. 91: 437-440. PMID 2210878 DOI: 10.1159/000235155  0.419
1990 van Dijken PJ, Ghayur T, Mauch P, Down J, Burakoff SJ, Ferrara JL. Evidence that anti-LFA-1 in vivo improves engraftment and survival after allogeneic bone marrow transplantation. Transplantation. 49: 882-6. PMID 2186521 DOI: 10.1097/00007890-199005000-00009  0.372
1990 Diamond DC, Finberg R, Chaudhuri S, Sleckman BP, Burakoff SJ. Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4. Proceedings of the National Academy of Sciences of the United States of America. 87: 5001-5. PMID 2142306 DOI: 10.1073/Pnas.87.13.5001  0.63
1990 Bierer BE, Mattila PS, Standaert RF, Herzenberg LA, Burakoff SJ, Crabtree G, Schreiber SL. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proceedings of the National Academy of Sciences of the United States of America. 87: 9231-5. PMID 2123553 DOI: 10.1073/Pnas.87.23.9231  0.364
1990 Maziarz RT, Mentzer SJ, Burakoff SJ, Faller DV. Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis. Cellular Immunology. 130: 329-38. PMID 2119892 DOI: 10.1016/0008-8749(90)90276-W  0.403
1990 Finberg RW, Diamond DC, Mitchell DB, Rosenstein Y, Soman G, Norman TC, Schreiber SL, Burakoff SJ. Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120. Science (New York, N.Y.). 249: 287-91. PMID 2115689 DOI: 10.1126/Science.2115689  0.632
1990 Maziarz RT, Burakoff SJ, Faller DV. The regulation of exogenous and endogenous class I MHC genes in a human tumor cell line, K562. Molecular Immunology. 27: 135-42. PMID 2108324 DOI: 10.1016/0161-5890(90)90108-C  0.344
1990 Bierer BE, Somers PK, Wandless TJ, Burakoff SJ, Schreiber SL. Probing immunosuppressant action with a nonnatural immunophilin ligand. Science (New York, N.Y.). 250: 556-9. PMID 1700475 DOI: 10.1126/Science.1700475  0.355
1989 Santos-Aguado J, Crimmins MA, Mentzer SJ, Burakoff SJ, Strominger JL. Alloreactivity studied with mutants of HLA-A2. Proceedings of the National Academy of Sciences of the United States of America. 86: 8936-40. PMID 2813431 DOI: 10.1073/Pnas.86.22.8936  0.371
1989 Stringfellow MM, Wilson RE, Burakoff SJ, Herrmann SH. Effect of Timing of Lymphokine Presentation on Generation of Cytotoxic T Lymphocytes Archives of Surgery. 124: 81-84. PMID 2783364 DOI: 10.1001/Archsurg.1989.01410010091019  0.355
1989 Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ. The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annual Review of Immunology. 7: 579-99. PMID 2653377 DOI: 10.1146/Annurev.Iy.07.040189.003051  0.445
1989 Ferrara JL, Guillen FJ, van Dijken PJ, Marion A, Murphy GF, Burakoff SJ. Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease. Transplantation. 47: 50-4. PMID 2643231 DOI: 10.1097/00007890-198901000-00012  0.385
1989 Sen J, Arceci RJ, Jones W, Burakoff SJ. Expression and ontogeny of murine CD2. European Journal of Immunology. 19: 1297-302. PMID 2569403 DOI: 10.1002/Eji.1830190722  0.444
1989 Mittler RS, Goldman SJ, Spitalny GL, Burakoff SJ. T-cell receptor-CD4 physical association in a murine T-cell hybridoma: Induction by antigen receptor ligation Proceedings of the National Academy of Sciences of the United States of America. 86: 8531-8535. PMID 2530583 DOI: 10.1073/Pnas.86.21.8531  0.492
1989 Bierer BE, Golan DE, Brown CS, Herrmann SH, Burakoff SJ. A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins. European Journal of Immunology. 19: 661-5. PMID 2471647 DOI: 10.1002/Eji.1830190414  0.564
1989 Macklis RM, Kaplan WD, Ferrara JL, Atcher RW, Hines JJ, Burakoff SJ, Coleman CN. Alpha particle radio-immunotherapy: animal models and clinical prospects. International Journal of Radiation Oncology, Biology, Physics. 16: 1377-87. PMID 2470706 DOI: 10.1016/0360-3016(89)90938-3  0.333
1989 Rosenstein Y, Ratnofsky S, Burakoff SJ, Herrmann SH. Direct evidence for binding of CD8 to HLA class I antigens. Journal of Experimental Medicine. 169: 149-160. PMID 2462606 DOI: 10.1084/Jem.169.1.149  0.537
1989 Bierer BE, Burakoff SJ, Smith BR. A Large Proportion of T Lymphocytes Lack CD5 Expression After Bone Marrow Transplantation Blood. 73: 1359-1366. DOI: 10.1182/Blood.V73.5.1359.Bloodjournal7351359  0.497
1989 Bierer B, Burakoff S, Smith B. A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation Blood. 73: 1359-1366. DOI: 10.1182/blood.v73.5.1359.1359  0.399
1989 Strominger JL, Fabbi M, Prendergast M, Maziarz RT, Burakoff SJ, Groh V. Novel subsets of human T cells (CD4+ CD8+ TCRγδ and CD4− CD8− TCRαβ) and T-cell development International Journal of Cancer. 44: 43-47. DOI: 10.1002/Ijc.2910440712  0.417
1988 Macklis RM, Kaplan WD, Ferrara JL, Kinsey BM, Kassis AI, Burakoff SJ. Biodistribution studies of anti-Thy 1.2 IgM immunoconjugates: implications for radioimmunotherapy. International Journal of Radiation Oncology, Biology, Physics. 15: 383-9. PMID 3403319 DOI: 10.1016/S0360-3016(98)90020-7  0.429
1988 Mentzer SJ, Wilson RE, Burakoff SJ, Herrmann SH. Membrane-bound anti-CD3 monoclonal antibodies trigger cytolytic T-lymphocyte-mediated tumor lysis. Archives of Surgery. 123: 1280-1285. PMID 3263103 DOI: 10.1001/Archsurg.1988.01400340106019  0.51
1988 Bierer BE, Emerson SG, Antin J, Maziarz R, Rappeport JM, Smith BR, Burakoff SJ. Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation. Transplantation. 46: 835-839. PMID 3061078 DOI: 10.1097/00007890-198812000-00009  0.515
1988 Bierer BE, Greenstein JL, Sleckman B, Ratnofsky S, Peterson A, Seed B, Burakoff SJ. Functional analysis of CD2, CD4, and CD8 in T-cell activation. Annals of the New York Academy of Sciences. 532: 199-206. PMID 3052208 DOI: 10.1111/J.1749-6632.1988.Tb36338.X  0.733
1988 Mentzer SJ, Herrmann SH, Crimmins MA, Burakoff SJ, Faller DV. The role of CD18 in phorbol ester-induced human monocyte-mediated cytotoxicity. Cellular Immunology. 115: 66-77. PMID 2900074 DOI: 10.1016/0008-8749(88)90162-1  0.455
1988 Kinsey BM, Macklis RM, Ferrara JM, Layne WW, Burakoff SJ, Kassis AI. Efficient conjugation of DTPA to an IgM monoclonal antibody in ascites fluid. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 15: 285-92. PMID 2898458 DOI: 10.1016/0883-2897(88)90108-0  0.372
1988 Macklis RM, Kinsey BM, Kassis AI, Ferrara JL, Atcher RW, Hines JJ, Coleman CN, Adelstein SJ, Burakoff SJ. Radioimmunotherapy with alpha-particle-emitting immunoconjugates. Science (New York, N.Y.). 240: 1024-6. PMID 2897133 DOI: 10.1126/Science.2897133  0.389
1988 Petrarca MA, Reiss CS, Diamond DC, Boni J, Burakoff SJ, Faller DV. T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection. Microbial Pathogenesis. 5: 319-32. PMID 2853279 DOI: 10.1016/0882-4010(88)90033-2  0.463
1988 Bierer BE, Burakoff SJ. T cell adhesion molecules. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 2: 2584-90. PMID 2838364 DOI: 10.1096/Fasebj.2.10.2838364  0.537
1988 Bierer BE, Peterson A, Gorga JC, Herrmann SH, Burakoff SJ. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor Journal of Experimental Medicine. 168: 1145-1156. PMID 2459290 DOI: 10.1084/Jem.168.3.1145  0.532
1988 Nishimura Y, Bierer BE, Jones WK, Jones NH, Strominger JL, Burakoff SJ. Expression and function of a CD5 cDNA in human and murine T cells. European Journal of Immunology. 18: 747-53. PMID 2454193 DOI: 10.1002/Eji.1830180514  0.461
1988 Bierer BE, Nishimura Y, Burakoff SJ, Smith BR. Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5. The Journal of Clinical Investigation. 81: 1390-7. PMID 2452832 DOI: 10.1172/Jci113468  0.457
1988 Bierer BE, Peterson A, Barbosa J, Seed B, Burakoff SJ. Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation Proceedings of the National Academy of Sciences of the United States of America. 85: 1194-1198. PMID 2448792 DOI: 10.1073/Pnas.85.4.1194  0.528
1988 FERRARA JLM, MICHAELSON J, BURAKOFF SJ, MAUCH P. ENGRAFTMENT FOLLOWING T CELL-DEPLETED BONE MARROW TRANSPLANTATION Transplantation. 45: 948-952. DOI: 10.1097/00007890-198805000-00022  0.309
1987 Mentzer SJ, Remold-O'Donnell E, Crimmins MA, Bierer BE, Rosen FS, Burakoff SJ. Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. The Journal of Experimental Medicine. 165: 1383-92. PMID 3572301 DOI: 10.1084/Jem.165.5.1383  0.49
1987 Mentzer SJ, Crimmins MA, Burakoff SJ, Faller DV. Alpha and beta subunits of the LFA-1 membrane molecule are involved in human monocyte-endothelial cell adhesion. Journal of Cellular Physiology. 130: 410-5. PMID 3549743 DOI: 10.1002/Jcp.1041300314  0.358
1987 Ratnofsky SE, Peterson A, Greenstein JL, Burakoff SJ. Expression and function of CD8 in a murine T cell hybridoma. The Journal of Experimental Medicine. 166: 1747-57. PMID 3500266 DOI: 10.1084/Jem.166.6.1747  0.766
1987 Ferrara JLM, Mauch P, McIntyre J, Michaelson J, Burakoff SJ. Engraftment following T-cell-depleted bone marrow transplantation: II. Stability of mixed chimerism in semiallogeneic recipients after total-body irradiation Transplantation. 44: 495-499. PMID 3313836 DOI: 10.1097/00007890-198710000-00007  0.35
1987 Takai Y, Reed ML, Burakoff SJ, Herrmann SH. Direct evidence for a receptor-ligand interaction between the T-cell surface antigen CD2 and lymphocyte-function-associated antigen 3. Proceedings of the National Academy of Sciences of the United States of America. 84: 6864-8. PMID 3309949 DOI: 10.1073/Pnas.84.19.6864  0.589
1987 Bierer BE, Herrmann SH, Brown CS, Burakoff SJ, Golan DE. Lateral mobility of class I histocompatibility antigens in B lymphoblastoid cell membranes: Modulation by cross-linking and effect of cell density Journal of Cell Biology. 105: 1147-1152. PMID 3115995 DOI: 10.1083/Jcb.105.3.1147  0.397
1987 Greenstein JL, Burakoff SJ. The role of L3T4 (CD4) in T-cell activation. Annales De L'Institut Pasteur. Immunology. 138: 134-8. PMID 3107586 DOI: 10.1016/S0769-2625(87)80104-6  0.768
1987 Sleckman BP, Peterson A, Jones WK, Foran JA, Greenstein JL, Seed B, Burakoff SJ. Expression and function of CD4 in a murine T-cell hybridoma. Nature. 328: 351-3. PMID 3037388 DOI: 10.1038/328351A0  0.791
1987 Rosoff PM, Burakoff SJ, Greenstein JL. The role of the L3T4 molecule in mitogen and antigen-activated signal transduction. Cell. 49: 845-53. PMID 3034434 DOI: 10.1016/0092-8674(87)90622-2  0.719
1987 Barbosa JA, Santos-Aguado J, Mentzer SJ, Strominger JL, Burakoff SJ, Biro PA. Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition. The Journal of Experimental Medicine. 166: 1329-50. PMID 2445888 DOI: 10.1084/Jem.166.5.1329  0.373
1987 Daley J, Rozans M, Smith B, Burakoff S, Rappeport J, Miller R. Retarded recovery of functional T cell frequencies in T cell-depleted bone marrow transplant recipients Blood. 70: 960-964. DOI: 10.1182/Blood.V70.4.960.Bloodjournal704960  0.445
1986 Mentzer SJ, Guyre PM, Burakoff SJ, Faller DV. Spontaneous aggregation as a mechanism for human monocyte purification. Cellular Immunology. 101: 312-9. PMID 3757046 DOI: 10.1016/0008-8749(86)90144-9  0.442
1986 Mentzer SJ, Bierer BE, Anderson DC, Springer TA, Burakoff SJ. Abnormal cytolytic activity of lymphocyte function-associated antigen-1-deficient human cytolytic T lymphocyte clones. The Journal of Clinical Investigation. 78: 1387-91. PMID 3534001 DOI: 10.1172/Jci112725  0.492
1986 Ferrara J, Guillen FJ, Sleckman B, Burakoff SJ, Murphy GF. Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: Histologic analysis and correlation to clinical disease Journal of Investigative Dermatology. 86: 371-375. PMID 3528309 DOI: 10.1111/1523-1747.Ep12285612  0.423
1986 Mentzer SJ, Burakoff SJ, Faller DV. Adhesion of T lymphocytes to human endothelial cells is regulated by the LFA-1 membrane molecule. Journal of Cellular Physiology. 126: 285-90. PMID 3511078 DOI: 10.1002/Jcp.1041260219  0.481
1986 Gorga JC, Knudsen PJ, Foran JA, Strominger JL, Burakoff SJ. Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures Cellular Immunology. 103: 160-173. PMID 3492282 DOI: 10.1016/0008-8749(86)90077-8  0.453
1986 Sung KL, Sung LA, Crimmins M, Burakoff SJ, Chien S. Determination of junction avidity of cytolytic T cell and target cell. Science (New York, N.Y.). 234: 1405-8. PMID 3491426 DOI: 10.1126/Science.3491426  0.428
1986 Murre C, Parker KC, Reiss CS, Driller JP, Wiley DC, Burakoff SJ, Seidman JG. Biochemical and functional analyses of a secreted H-2Ld molecule. Molecular and Cellular Biology. 6: 1315-9. PMID 3491290 DOI: 10.1128/Mcb.6.4.1315  0.373
1986 Rozans MK, Smith BR, Emerson S, Crimmins M, Laurent G, Reichert T, Burakoff SJ, Miller RA. Functional assessment of T cell depletion from bone marrow prior to therapeutic transplantation using limiting dilution culture methods. Transplantation. 42: 380-7. PMID 3094209 DOI: 10.1097/00007890-198610000-00010  0.485
1986 Greenstein JL, Herrmann SH, Sunshine GH, Burakoff SJ. The mechanism of antigen presentation by dendritic cells and splenic adherent cells in the induction of an allogeneic cytotoxic T-lymphocyte response to H-2Kk liposomes. Cellular Immunology. 100: 389-99. PMID 2944605 DOI: 10.1016/0008-8749(86)90038-9  0.748
1986 Mentzer SJ, Krensky AM, Burakoff SJ. Mapping functional epitopes of the human LFA-1 glycoprotein: Monoclonal antibody ingibition of NK and CTL effectors Human Immunology. 17: 288-296. PMID 2432044 DOI: 10.1016/0198-8859(86)90280-6  0.426
1986 Maziarz RT, Fraser J, Strominger JL, Burakoff SJ. The human HLA-specific monoclonal antibody W6/32 recognizes a discontinuous epitope within the alpha 2 domain of murine H-2Db. Immunogenetics. 24: 206-8. PMID 2428745 DOI: 10.1007/Bf00364750  0.31
1986 Maziarz RT, Burakoff SJ, Reiss CS. Viral-restricted cytolytic T lymphocyte recognition of hybrid human-murine class I histocompatibility antigens. Cellular Immunology. 99: 279-286. PMID 2428530 DOI: 10.1016/0008-8749(86)90235-2  0.473
1985 Pober JS, Gimbrone MA, Collins T, Cotran RS, Ault KA, Fiers W, Krensky AM, Clayberger C, Reiss CS, Burakoff SJ. Interactions of T lymphocytes with human vascular endothelial cells: role of endothelial cells surface antigens. Immunobiology. 168: 483-94. PMID 6397428 DOI: 10.1016/S0171-2985(84)80132-1  0.501
1985 Barbosa JA, Mentzer SJ, Minowada G, Strominger JL, Burakoff SJ, Biro PA. Recognition of HLA-A2 and -B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse, cells. Proceedings of the National Academy of Sciences of the United States of America. 81: 7549-53. PMID 6390442 DOI: 10.1073/Pnas.81.23.7549  0.433
1985 Greenstein JL, Malissen B, Burakoff SJ. Role of L3T4 in antigen-driven activation of a class I-specific T cell hybridoma. The Journal of Experimental Medicine. 162: 369-74. PMID 3925069 DOI: 10.1084/Jem.162.1.369  0.77
1985 Springer TA, Rothlein R, Anderson DC, Burakoff SJ, Krensky AM. The function of LFA-1 in cell-mediated killing and adhesion: studies on heritable LFA-1, Mac-1 deficiency and on lymphoid cell self-aggregation. Advances in Experimental Medicine and Biology. 184: 311-22. PMID 3898754 DOI: 10.1007/978-1-4684-8326-0_21  0.474
1985 Maziarz R, Allen H, Strominger JL, Flavell R, Biro PA, Burakoff SJ. Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 82: 6276-80. PMID 3875858 DOI: 10.1073/Pnas.82.18.6276  0.405
1985 O'Flynn K, Krensky AM, Beverley PC, Burakoff SJ, Linch DC. Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor. Nature. 313: 686-7. PMID 3871914 DOI: 10.1038/313686A0  0.465
1985 Umetsu DT, Pober JS, Jabara HH, Fiers W, Yunis EJ, Burakoff SJ, Reiss CS, Geha RS. Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones. The Journal of Clinical Investigation. 76: 254-60. PMID 3160726 DOI: 10.1172/Jci111955  0.478
1985 Weis JH, Reiss CS, Mulligan RC, Burakoff SJ, Seidman JG. H-2Ld antigen encoded by a recombinant retrovirus genome is expressed on the surface of infected cells. Molecular and Cellular Biology. 5: 1379-84. PMID 2993861 DOI: 10.1128/Mcb.5.6.1379  0.386
1985 Weinberger O, Herrmann SH, Greenstein JL, Mescher MF, Burakoff SJ. The ability of Ia and H-2Kk-bearing membranes to replace the antigen-presenting cell in an H-2Kk allogeneic cytotoxic T cell response. European Journal of Immunology. 15: 1013-8. PMID 2932336 DOI: 10.1002/Eji.1830151010  0.815
1985 Miller BA, Lipton JM, Linch DC, Burakoff SJ, Nathan DG. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors Journal of Cellular Physiology. 123: 25-32. PMID 2857726 DOI: 10.1002/Jcp.1041230105  0.378
1985 Heilig JS, Glimcher LH, Kranz DM, Clayton LK, Greenstein JL, Saito H, Maxam AM, Burakoff SJ, Eisen HN, Tonegawa S. Expression of the T-cell-specific gamma gene is unnecessary in T cells recognizing class II MHC determinants. Nature. 317: 68-70. PMID 2412133 DOI: 10.1038/317068A0  0.73
1984 Murre C, Reiss CS, Bernabeu C, Chen LB, Burakoff SJ, Seidman JG. Construction, expression and recognition of an H - 2 molecule lacking its carboxyl terminus Nature. 307: 432-436. PMID 6363940 DOI: 10.1038/307432A0  0.363
1984 Gorga JC, Foran J, Burakoff SJ, Strominger JL. Use of the HLA-DR antigens incorporated into liposomes to generate HLA-DR specific cytotoxic T lymphocytes Methods in Enzymology. 607-613. PMID 6335556 DOI: 10.1016/S0076-6879(84)08121-0  0.464
1984 Stallcup KC, Burakoff SJ, Mescher MF. Inhibition of normal lymphocyte responses by cell membranes Cellular Immunology. 89: 144-150. PMID 6333285 DOI: 10.1016/0008-8749(84)90205-3  0.648
1984 Stallcup KC, Burakoff SJ, Mescher MF. Growth-inhibitory activity of lymphoid cell plasma membranes. II. Partial characterization of the inhibitor Journal of Cell Biology. 99: 1227-1234. PMID 6332814 DOI: 10.1083/Jcb.99.4.1227  0.645
1984 Burakoff SJ, Weinberger O, Krensky AM, Reiss CS. A molecular analysis of the cytolytic T lymphocyte response. Advances in Immunology. 36: 45-85. PMID 6239523 DOI: 10.1016/S0065-2776(08)60899-8  0.467
1984 Murre C, Choi E, Weis J, Seidman JG, Ozato K, Liu L, Burakoff SJ, Reiss CS. Dissection of serological and cytolytic T lymphocyte epitopes on murine major histocompatibility antigens by a recombinant H-2 gene separating the first two external domains Journal of Experimental Medicine. 160: 167-178. PMID 6203998 DOI: 10.1084/Jem.160.1.167  0.367
1984 Greenstein JL, Kappler J, Marrack P, Burakoff SJ. The role of L3T4 in recognition of Ia by a cytotoxic, H-2Dd-specific T cell hybridoma. The Journal of Experimental Medicine. 159: 1213-24. PMID 6200564 DOI: 10.1084/Jem.159.4.1213  0.807
1983 Flyer DC, Burakoff SJ, Faller DV. Cytotoxic T lymphocyte recognition of transfected cells expressing a cloned retroviral gene. Nature. 305: 815-8. PMID 6605480 DOI: 10.1038/305815A0  0.458
1983 Krensky AM, Burakoff SJ. Basic Science Seminar: Cytotoxic T-lymphocyteresponse to HLA antigens The Journal of Pediatrics. 102: 814-819. PMID 6602213 DOI: 10.1016/S0022-3476(83)80004-3  0.435
1983 Pober JS, Collins T, Gimbrone MA, Cotran RS, Gitlin JD, Fiers W, Clayberger C, Krensky AM, Burakoff SJ, Reiss CS. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon Nature. 305: 726-729. PMID 6415484 DOI: 10.1038/305726A0  0.507
1983 Pober JS, Gimbrone MA, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. The Journal of Experimental Medicine. 157: 1339-53. PMID 6403654 DOI: 10.1084/Jem.157.4.1339  0.469
1983 Reiss CS, Evans GA, Margulies DH, Seidman JG, Burakoff SJ. Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer. Proceedings of the National Academy of Sciences of the United States of America. 80: 2709-12. PMID 6302702 DOI: 10.1073/Pnas.80.9.2709  0.397
1983 Weinberger O, Germain RN, Burakoff SJ. Responses to the H-2Kba mutant involve recognition of syngeneic Ia molecules. Nature. 302: 429-31. PMID 6220226 DOI: 10.1038/302429A0  0.665
1983 Ben-Nun A, Lando Z, Dorf ME, Burakoff SJ. Analysis of cross-reactive antigen-specific T cell clones. Specific recognition of two major histocompatibility complex (MHC) and two non-MHC antigens by a single clone. The Journal of Experimental Medicine. 157: 2147-53. PMID 6189955 DOI: 10.1084/Jem.157.6.2147  0.444
1982 Sanchez-Madrid F, Krensky AM, Ware CF, Robbins E, Strominger JL, Burakoff SJ, Springer TA. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proceedings of the National Academy of Sciences of the United States of America. 79: 7489-93. PMID 6984191 DOI: 10.1073/Pnas.79.23.7489  0.469
1982 Mescher MF, Balk SP, Burakoff SJ, Herrmann SH. Cytolytic T lymphocyte recognition of subcellular antigen Advances in Experimental Medicine and Biology. 146: 41-55. PMID 6980567 DOI: 10.1007/978-1-4684-8959-0_3  0.677
1982 Krensky AM, Reiss CS, Mier JW, Strominger JL, Burakoff SJ. Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proceedings of the National Academy of Sciences of the United States of America. 79: 2365-9. PMID 6980419 DOI: 10.1073/Pnas.79.7.2365  0.465
1982 Gualde N, Weinberger O, Ratnofsky S, Benacerraf B, Burakoff SJ. In vitro generation of helper T cells and suppressor T cells that regulate the cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. Transplantation. 33: 422-6. PMID 6461956 DOI: 10.1097/00007890-198204000-00016  0.625
1982 Duprez, Hamilton B, Burakoff SJ. Generation of cytolytic t lymphocytes in thymectomized, irradiated, and bone marrow-reconstituted mice. Journal of Experimental Medicine. 156: 844-859. PMID 6125557 DOI: 10.1084/Jem.156.3.844  0.429
1981 Reiss CS, Burakoff SJ. Specificity of the helper T cell for the cytolytic T lymphocyte response to influenza viruses. Journal of Experimental Medicine. 154: 541-546. PMID 6973607 DOI: 10.1084/Jem.154.2.541  0.464
1981 Weinberger O, Herrmann S, Mescher MF, Benacerraf B, Burakoff SJ. Cellular interactions in the generation of cytolytic T lymphocyte responses. Analysis of the helper T cell pathway. European Journal of Immunology. 11: 405-11. PMID 6973476 DOI: 10.1002/Eji.1830110511  0.731
1981 Weinberger O, Herrmann S, Mescher MF, Benacerraf B, Burakoff SJ. Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing. Proceedings of the National Academy of Sciences of the United States of America. 78: 1796-9. PMID 6972042 DOI: 10.1073/Pnas.78.3.1796  0.752
1981 Finberg R, Weiner HL, Burakoff SJ, Fields BN. Type-specific reovirus antiserum blocks the cytotoxic T-cell-target cell interaction: evidence for the association of the viral hemagglutinin of a nonenveloped virus with the cell surface. Infection and Immunity. 31: 646-649. PMID 6971263 DOI: 10.1128/Iai.31.2.646-649.1981  0.641
1980 Burakoff SJ, Reiss CS, Finberg R, Mescher MF. Cell-mediated immunity to viral glycoproteins Reviews of Infectious Diseases. 2: 62-78. PMID 6994203 DOI: 10.1093/Clinids/2.1.62  0.739
1980 Weinberger O, Herrmann SH, Mescher MF, Benacerraf B, Burakoff SJ. Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen. Proceedings of the National Academy of Sciences of the United States of America. 77: 6091-5. PMID 6969401 DOI: 10.1073/Pnas.77.10.6091  0.747
1980 Reiss CS, Hemler ME, Englehard VH, Mier JW, Strominger JL, Burakoff SJ. Development and characterization of allospecific long-term human cytolytic T-cell lines. Proceedings of the National Academy of Sciences of the United States of America. 77: 5432-6. PMID 6968913 DOI: 10.1073/Pnas.77.9.5432  0.445
1980 Sherman L, Burakoff SJ, Mescher MF. Induction of allogeneic cytolytic T lymphocytes by partially purified membrane glycoproteins Cellular Immunology. 51: 141-150. PMID 6767550 DOI: 10.1016/0008-8749(80)90244-0  0.662
1980 Abbas AK, Burakoff SJ, Gefter ML, Greene MI. T lymphocyte-mediated suppression of myeloma function in vitro. III. Regulation of antibody production in hybrid myeloma cells by T lymphocytes Journal of Experimental Medicine. 152: 968-978. PMID 6158552 DOI: 10.1084/Jem.152.4.969  0.512
1980 Abbas AK, Ratnofsky SE, Burakoff SJ. T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten-specific cytolytic T lymphocytes. The Journal of Experimental Medicine. 152: 306-23. PMID 6156985 DOI: 10.1084/Jem.152.2.306  0.524
1980 Burakoff SJ, Engelhard VH, Kaufman J, Strominger JL. Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens [23] Nature. 283: 495-497. PMID 6153237 DOI: 10.1038/283495A0  0.485
1979 Finberg R, Weiner HL, Fields BN, Benacerraf B, Burakoff SJ. Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proceedings of the National Academy of Sciences of the United States of America. 76: 442-6. PMID 218202 DOI: 10.1073/Pnas.76.1.442  0.695
1979 Finberg R, Mescher M, Burakoff SJ. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins. The Journal of Experimental Medicine. 148: 1620-7. PMID 214512 DOI: 10.1084/Jem.148.6.1620  0.701
1979 Vadas MA, Butterworth AE, Burakoff S, Sher A. Major histocompatibility complex products restrict the adherence of cytolytic T lymphocytes to minor histocompatibility antigens or to trinitrophenyl determinants on schistosomula of Schistosoma mansoni. Proceedings of the National Academy of Sciences of the United States of America. 76: 1982-1985. PMID 88051 DOI: 10.1073/Pnas.76.4.1982  0.45
1978 Engelhard VH, Strominger JL, Mescher M, Burakoff S. Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles Proceedings of the National Academy of Sciences of the United States of America. 75: 5688-5691. PMID 310125 DOI: 10.1073/Pnas.75.11.5688  0.711
1978 Mescher M, Sherman L, Lemonnier F, Burakoff S. The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins. The Journal of Experimental Medicine. 147: 946-51. PMID 305464 DOI: 10.1084/Jem.147.3.946  0.668
1978 Finberg R, Burakoff SJ, Cantor H, Benacerraf B. Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proceedings of the National Academy of Sciences of the United States of America. 75: 5145-9. PMID 217013 DOI: 10.1073/Pnas.75.10.5145  0.71
1978 Burakoff SJ, Finberg R, Glimcher L, Lemonnier F, Benacerraf B, Cantor H. The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens. The Journal of Experimental Medicine. 148: 1414-22. PMID 214510 DOI: 10.1084/Jem.148.5.1414  0.727
1978 Billings P, Burakoff SJ, Dorf ME, Benacerraf B. Genetic control of cytolytic t-lymphocyte responses. II. The role of the host genotype in parental leads to F1 radiation chimeras in the control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells. The Journal of Experimental Medicine. 148: 352-9. PMID 100568 DOI: 10.1084/Jem.148.2.352  0.572
1978 Billings P, Burakoff SJ, Dorf ME, Benacerraf B. Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells. The Journal of Experimental Medicine. 148: 341-50. PMID 100567 DOI: 10.1084/Jem.148.2.341  0.544
1977 Burakoff SJ, Ratnofsky SE, Benacerraf B. Mouse cytolytic T lymphocytes induced by xenogeneic rat stimulator cells exhibit specificity for H-2 complex alloantigens. Proceedings of the National Academy of Sciences of the United States of America. 74: 4572-6. PMID 73180 DOI: 10.1073/Pnas.74.10.4572  0.604
1977 Billings P, Burakoff S, Dorf ME, Benacerraf B. Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells. The Journal of Experimental Medicine. 146: 623-8. PMID 69009 DOI: 10.1084/Jem.146.2.623  0.535
1977 Billings P, Burakoff S, Dorf ME, Benacerraf B. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products. The Journal of Experimental Medicine. 145: 1387-92. PMID 67179 DOI: 10.1084/Jem.145.5.1387  0.506
1976 Burakoff SJ, Germain RN, Benacerraf B. Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells. The Journal of Experimental Medicine. 144: 1609-20. PMID 1087327 DOI: 10.1084/Jem.144.6.1609  0.658
1976 Burakoff SJ, Germain RN, Dorf ME, Benacerrah B. Inhibition of cell-mediated cytolysis of trinitrophenyl-derivatized target cells by alloantisera directed to the products of the K and D loci of the H-2 complex. Proceedings of the National Academy of Sciences of the United States of America. 73: 625-9. PMID 1082140 DOI: 10.1073/Pnas.73.2.625  0.599
1975 Burakoff SJ, Martz E, Benacerraf B. Is the primary complement lesion insufficient for lysis? Failure of cells damaged under osmotic protection to lyse in EDTA or at low temperature after removal of osmotic protection. Clinical Immunology and Immunopathology. 4: 108-26. PMID 805009 DOI: 10.1016/0090-1229(75)90045-8  0.49
1974 Martz E, Burakoff SJ, Benacerraf B. Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T-cells or complement. Proceedings of the National Academy of Sciences of the United States of America. 71: 177-81. PMID 4359327 DOI: 10.1073/Pnas.71.1.177  0.585
Show low-probability matches.